Government removes ban on UK-sourced blood plasma for the manufacture of immunoglobulins

The ban was introduced in 1998 in response to concerns over the spread of a human variant of BSE. The Commission on Human Medicines has now advised the use of UK-sourced plasma to manufacture these treatments is safe and can recommence supported by a set of robust safety measures

Department of Health and Social Care